Search

Search Constraints

You searched for: Author/Creator Mileshkin, Linda

Search Results

42. Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial. Issue 5 (May 2021)

46. Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial. Issue 9 (September 2019)

47. Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study. Issue 7 (1st March 2022)

48. Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists. Issue 4 (April 2017)

49. Pertuzumab and Erlotinib in Patients With Relapsed Non-Small Cell Lung Cancer: A Phase II Study Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging. (23rd January 2014)

50. Pertuzumab and Erlotinib in Patients With Relapsed Non‐Small Cell Lung Cancer: A Phase II Study Using 18F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging. (23rd January 2014)